RecruitingPhase 3NCT07029516

Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis

A Randomized, Double Blind, Placebo-controlled, Unicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of a Multi-funtion Toe Nail Patch in Patients Affected by Nail Fragility, Nail Mychosis and Psoriasis


Sponsor

Wooshin Labottach Co., Ltd.

Enrollment

72 participants

Start Date

Feb 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

A randomized, double blind, placebo-controlled, unicenter, parallel group study to assess the efficacy, safety and tolerability of a multi-funtion toe nail patch in patients affected by nail fragility, nail mychosis and psoriasis 72 patients in 6 subgroups Treatment duration 3 months + 1 month follow-up


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Cosmetic patch containing urea applicated daily for 3 months and Placebo patch application for people with mycosis, nail damage, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCosmetic patch containing urea applicated daily for 3 months

Daily application of the patch on toes, 3 months treatment

OTHERPlacebo patch application

Daily application of a placebo patch on toes for a 3 months treatment


Locations(1)

Clinica Dermatologica - Policlinico - Università degli Studi di Milano Via Francesco Sforza- Milano

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07029516


Related Trials